Trials / Recruiting
RecruitingNCT06730256
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
A Clinical Study to Explore the Safety, Efficacy, and Pharmacokinetics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- The First Affiliated Hospital of Soochow University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Clinical Study to Explore the Safety, Efficacy, and Cellular Metabolic Dynamics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Plasma Cell Leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CAR-T cells Infusion chimeric antigen receptor T cells | CAR-T cells Infusion chimeric antigen receptor T cells |
Timeline
- Start date
- 2025-07-23
- Primary completion
- 2027-01-03
- Completion
- 2027-12-31
- First posted
- 2024-12-12
- Last updated
- 2025-10-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06730256. Inclusion in this directory is not an endorsement.